Singapore markets close in 6 hours 59 minutes

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5700-0.0400 (-2.48%)
At close: 04:00PM EST
1.5800 +0.01 (+0.64%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.6100
Open1.6100
Bid1.5500 x 900
Ask1.5900 x 2200
Day's range1.5050 - 1.6100
52-week range0.4200 - 1.7900
Volume1,532,994
Avg. volume1,532,737
Market cap356.582M
Beta (5Y monthly)2.25
PE ratio (TTM)N/A
EPS (TTM)-0.5400
Earnings date06 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.38
  • Insider Monkey

    15 Top Performing European Stocks So Far in 2024

    In this piece, we will take a look at the 15 top performing European stocks so far in 2024. If you want to skip our overview of the European economy and the stock climate, then you can skip ahead to 5 Top Performing European Stocks So Far in 2024. Over the course of the past […]

  • Zacks

    Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know

    The latest trading day saw Adaptimmune Therapeutics PLC (ADAP) settling at $1.20, representing a -1.24% change from its previous close.

  • GuruFocus.com

    Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC

    On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, expanded its investment portfolio by adding a significant number of shares in Adaptimmune Therapeutics PLC (NASDAQ:ADAP). Baillie Gifford (Trades, Portfolio) has established itself as a prominent investment management partnership with over a century of experience.